Phase I trial of tideglusib in volunteers.
Phase of Trial: Phase I
Latest Information Update: 10 Mar 2009
At a glance
- Drugs Tideglusib (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Noscira
- 10 Mar 2009 Tolerability results have been reported in a Noscira media release.
- 18 Aug 2008 Status changed from recruiting to unconfirmed. According to a Neuropharma media release, a total of 140 subjects have received NP-031112 as of 31 Jul 08.
- 12 May 2006 New trial record.